Analysts think JAGX stock price could increase by 3369%
Apr 07, 2025, 11:25 AM
146.03%
What does JAGX do
Jaguar Health, a San Francisco-based pharmaceutical company with 49 employees, specializes in plant-derived medicines for gastrointestinal issues in humans and animals, including Mytesi for HIV patients and Canalevia-CA1 for dogs. The company went public on May 13, 2015, and operates through human and animal health segments.
3 analysts think JAGX stock price will increase by 3369.39%. The current median analyst target is $153.00 compared to a current stock price of $4.41. The lowest analysts target is $151.50 and the highest analyst target is $157.50.
📡️ Health Care
Price Target
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
